| AA | Arachidonic acid |
| 2-AG | 2-Arachidonoylglycerol |
| AC | Adenylate cyclase |
| AEA | Anandamide |
| ALT | Alanine aminotransferase |
| ATM | Adipose tissue macrophage |
| BBB | Blood–brain barrier |
| BMI | Body mass index |
| cAMP | Cyclic adenosine monophosphate |
| CB1R | Cannabinoid-receptor type 1 |
| CB2R | Cannabinoid-receptor type 2 |
| CBD | Cannabidiol |
| CBR | Cannabinoid receptor |
| CNS | Central nervous system |
| CRP | C-reactive protein |
| DA | Dopamine |
| DALY | Disability-adjusted life-years |
| DM | Diabetes mellitus |
| DN | Diabetic nephropathy |
| DPN | Diabetic peripheral neuropathy |
| DRP | Diabetic retinopathy |
| EAE | Experimental autoimmune encephalomyelitis |
| ECB | Endocannabinoid |
| ECS | Endocannabinoid system |
| ERK | Extracellular signal-regulated kinase |
| FAAH | Fatty acid amide hydrolase |
| FDA | Food and Drug Administration |
| FR | Fixed-ratio |
| GLUT 4 | Glucose transporter type 4 |
| GPCR | G-protein-coupled receptor |
| GSIS | Glucose-stimulated insulin secretion |
| HbA1C | Glycated hemoglobin |
| HDL | High-density lipoprotein |
| HOMA-IR | Homeostasis model assessment of insulin resistance |
| IDF | International Diabetes Federation |
| IKK-β | Inhibitor of nuclear factor kappa-B kinase subunit β |
| iNOS | Inducible NO synthase |
| IRF5 | Interferon regulatory factor-5 |
| JNK | c-Jun N-terminal kinase |
| MAPK | Mitogen-activated protein kinase |
| MEK | Mitogen-activated protein kinase kinase |
| MNU | N-Methyl-N-nitrosurea |
| NAc | Nucleus accumbens |
| nAChR | Nicotinic acetylcholine receptor |
| NCD | Non-communicable disease |
| NK | Natural killer |
| NLRP3 | Nucleotide-binding domain and leucine-rich repeat protein 3 |
| NSAID | Non-steroidal anti-inflammatory drug |
| PI3K | Phosphatidylinositol 3-kinase |
| PPAR | Peroxisome proliferator-activated receptor |
| PR | Progressive ratio |
| PUFA | Polyunsaturated fatty acid |
| R | Receptor |
| ROS | Reactive oxygen species |
| SC | Synthetic cannabinoid |
| sP | Sardinian alcohol-preferring |
| STRATUS | Studies with Rimonabant and Tobacco Use |
| STZ | Streptozotocin |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TNF-α | Tumor necrosis factor-α |
| TRPA1 | Transient receptor potential ankyrin 1 |
| TRPV1 | Transient receptor potential vanilloid 1 |
| US | United States |
| VTA | Ventral tegmental area |
| WHO | World Health Organization |
| ZDF | Zucker diabetic fatty |
| γ-GT | Gamma-glutamyl transferase |
| ∆8-THCV | ∆8-Tetrahydrocannabivarin |
| Δ9-THC | Δ9-Tetrahydrocannabinol |
| AA | Arachidonic acid |